1. Home
  2. ROMA vs AQST Comparison

ROMA vs AQST Comparison

Compare ROMA & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roma Green Finance Limited

ROMA

Roma Green Finance Limited

N/A

Current Price

$8.98

Market Cap

542.0M

Sector

Finance

ML Signal

N/A

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.77

Market Cap

529.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROMA
AQST
Founded
2018
2004
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.0M
529.4M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
ROMA
AQST
Price
$8.98
$4.77
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.00
AVG Volume (30 Days)
3.0K
3.4M
Earning Date
12-23-2025
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
N/A
$10.08
Revenue Next Year
N/A
$49.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.77
52 Week Low
$1.16
$2.94
52 Week High
$11.77
$7.55

Technical Indicators

Market Signals
Indicator
ROMA
AQST
Relative Strength Index (RSI) 50.90 55.64
Support Level $8.01 $4.03
Resistance Level $9.75 $5.10
Average True Range (ATR) 0.35 0.26
MACD -0.01 -0.02
Stochastic Oscillator 74.59 48.53

Price Performance

Historical Comparison
ROMA
AQST

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is a professional specialist in the provision of environmental, social and governance (ESG), sustainability and climate change related advisory services through its operating subsidiaries in Hong Kong and Singapore. Its services include Sustainability Program Development, ESG Reporting, Corporate Governance and Risk Management, Climate Change Strategies and Solutions, Environmental Audit, ESG Rating Support and Shareholder Communication, and Education and Training. It operates in one reporting business segment in Hong Kong and Singapore, of which the majority of revenue is derived from Hong Kong.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: